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Abstract 
Each heartbeat is triggered by a pulse of intracellular calcium ions which bind to troponin on 
the actin-containing thin filaments of heart muscle cells, initiating a change in filament 
structure that allows myosin to bind and generate force. We investigated the molecular 
mechanism of calcium regulation in demembranated trabeculae from rat ventricle using 
polarised fluorescence from probes on troponin C (TnC). Native TnC was replaced by 
double-cysteine mutants of human cardiac TnC with bifunctional rhodamine attached along 
either the C helix, adjacent to the regulatory Ca2+-binding site, or the E helix in the IT arm of 
the troponin complex. Changes in the orientation of both troponin helices had the same steep 
Ca2+-dependence as active force production, with a Hill coefficient (nH) close to 3, consistent 
with a single co-operative transition controlled by Ca2+ binding. Complete inhibition of active 
force by 25 μM blebbistatin had very little effect on the Ca2+-dependent structural changes 
and in particular did not significantly reduce the value of nH. Binding of rigor myosin heads 
to thin filaments following MgATP depletion in the absence of Ca2+ also changed the 
orientation of the C and E helices, and addition of Ca2+ in rigor produced further changes 
characterized by increased Ca2+ affinity but nH close to 1. These results show that, although 
myosin binding can switch on thin filaments in rigor conditions, it does not contribute 
significantly under physiological conditions. The physiological mechanism of co-operative 
Ca2+-regulation of cardiac contractility must therefore be intrinsic to the thin filaments.  
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Contraction of heart muscle is driven by an interaction between myosin, actin and MgATP 
that is controlled on a beat-to-beat basis by transient binding of Ca2+ ions to the 
troponin/tropomyosin complex in the actin-containing thin filaments (Tobacman, 1996; 
Gordon et al. 2000; Kobayashi & Solaro, 2005). Although the structures of most of the major 
protein components of the regulatory complex have been elucidated, the physiological 
mechanism of the control of cardiac contractility is not yet understood at the molecular level. 
Activation and relaxation of heart muscle cells occur over a narrow range of Ca2+ 
concentrations, and the steep Ca2+-dependence of the regulatory mechanism indicates a high 
degree of co-operativity. This might be due to coupling between adjacent 
actin/tropomyosin/troponin units in the thin filament (Tobacman, 1996; Tobacman & Sawyer, 
1990; Galinska-Rakoczy et al. 2008) or to activation of the thin filament by myosin binding 
(Bremel & Weber, 1972; Rosenfeld & Taylor, 1985; Robinson et al. 2004). Both these 
mechanisms can operate under specific conditions in vitro, but the nature of the structural 
changes and co-operative interactions that occur during physiological activation of the heart 
cannot be reliably extrapolated from in vitro studies.  
Here we have investigated the molecular mechanism of Ca2+ regulation of cardiac 
contractility in demembranated ventricular trabeculae, in which the native structural 
relationships between the full complement of proteins in the regulatory system are preserved. 
We attached bifunctional fluorescent probes to pairs of sites on specific α-helices of troponin, 
and the polarisation of the fluorescence reports the orientation of each helix with respect to 
the actin filament or muscle cell axis. The probe attachment sites were chosen using the high 
resolution structures of isolated troponin components, and engineered by expressing mutants 
of troponin C (TnC, the component of troponin containing the regulatory Ca2+ site) with 
cysteines at the chosen sites (Fig. 1A; Takeda et al., 2003). One TnC mutant had cysteines at 
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residues 55 and 62 (yellow spheres) on the C helix in the N-terminal lobe (red) of TnC, which 
contains the regulatory Ca2+ site (black sphere). Another TnC mutant had cysteines at 
positions 95 and 102 along the E helix in the IT arm, which is composed of the C-terminal 
half of TnC (green) containing two Ca2+/Mg2+ binding sites (grey), and parts of troponin I 
(TnI, blue) and troponin T (TnT, gold). 
The pair of cysteines in each of these TnC mutants was cross-linked with bifunctional 
rhodamine (BR) (Corrie et al. 1999; Ferguson et al. 2003; Sun et al. 2006), and each BR-TnC 
was separately exchanged for the native TnC of demembranated trabeculae from rat ventricle. 
Thus the two probes used here report changes in the orientation of the two major domains of 
the troponin core complex, the regulatory lobe of TnC and the IT arm, during Ca2+-dependent 
activation in the cellular environment. The relative orientation of these two domains differs 
substantially between published crystal structures of the core complex (Takeda et al. 2003; 
Vinogradova et al. 2005), and a change in this relative orientation may play a key role in the 
regulatory mechanism (Sun et al. 2006). We also investigated the role of myosin in the 
regulatory mechanism by inhibiting active force with blebbistatin (Straight et al, 2003; Dou 
et al. 2007; Farman et al. 2008), and by inducing rigor binding of myosin heads by MgATP 
depletion. 
 
 
Methods 
Animals 
Wistar rats (200–250 g) were stunned and killed by cervical dislocation (Schedule 1 
procedure in accordance with UK Animal (Scientific Procedures) Act 1986). The hearts were 
removed and rinsed free of blood in Krebs solution containing (mM): NaCl, 118; NaHCO3, 
24.8; Na2HPO4, 1.18; MgSO4, 1.18; KCl, 4.75; CaCl2, 2.54; glucose, 10; bubbled with 95% 
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O2–5% CO2; pH 7.4 at 20 °C. Suitable trabeculae (free running, unbranched, diameter < 250 
µm) were dissected from the right ventricle in Krebs solution containing 25 mM 2,3-
butanedione-monoxime, permeabilised in relaxing solution (see below) containing 1% Triton 
X-100 for 30 min, and stored in relaxing solution containing 50% (vol/vol) glycerol at -20 °C 
for experiments, normally within 2 days of dissection.  
 
Preparation of BR labelled troponin C 
Double cysteine mutants E55C/D62C and E95C/R102C of human cardiac TnC in the Pet3a 
expression vector were obtained by site-directed mutagenesis and expressed in E. coli.  C35 
and C84 were replaced by serine. TnC was expressed, purified and labelled as described 
previously for the skeletal isoform (Ferguson et al. 2003). The cysteines were cross-linked 
with bifunctional rhodamine (BR) to form 1:1 BR:TnC conjugates (Corrie et al. 1998), and 
purified to >95% homogeneity by reverse-phase HPLC. Stoichiometry and specificity of BR-
labeling were confirmed by electrospray mass spectrometry. The measured mass of TnC with 
BR crosslinking residues 55 and 62 (TnC-BR55-62) was 18,858.5 ± 0.9 Da (calculated mass 
18,858.6 Da), and that of TnC-BR95-102 was 18,817.9 ± 0.8 Da (calculated mass 18,817.3 Da). 
 
Reconstitution of TnC into ventricular trabeculae 
Demembranated trabeculae were mounted, via aluminium T-clips, at sarcomere length 2.1–
2.2 µm between a force transducer (AE 801) and a fixed hook in a 60 µl glass trough 
containing relaxing solution. The experimental temperature was 20–22 °C. 
Experimental solutions contained 25 mM imidazole, 5 mM MgATP (except rigor 
solutions), 1 mM free Mg2+, 10 mM EGTA (except pre-activating solution), 0 – 10 mM total 
calcium, 1 mM dithiothreitol and 0.1% (vol/vol) protease inhibitor cocktail (P8340, Sigma). 
Ionic strength was adjusted to 200 mM with potassium propionate; pH was 7.1 at 20 °C. The 
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purity of EGTA (E4378, Sigma) was 98.7% according to the manufacturer’s analysis. The 
concentration of free Ca2+ was calculated using the program WinMAXC V2.5 
(http://www.stanford.edu/~cpatton/maxc.html). The calculated free [Ca2+] was in the range 
1 nM to 63 µM in the presence of MgATP and 1 nM to 158 µM in its absence. In pre-
activating solution, [EGTA] was 0.2 mM and no calcium was added. When required, 25 µM 
blebbistatin (B0560, Sigma) was added from a 10 mM stock solution in DMSO. 
Native TnC was extracted from trabeculae by incubation in 0.5 mM trifluoperazine 
(Fluka 91665), 20 mM MOPS, 5 mM EDTA and 130 mM potassium propionate, pH 7.0, 
20°C for 30 s, followed by 30 s in relaxing solution. After 20–25 such cycles, the residual 
force at maximal Ca2+ activation at [Ca2+] = 63 µM was 30 ± 3% (n=14) of its pre-extraction 
value, indicating that about two-thirds of the native TnC had been removed. 
Trifluoperazine as used in this TnC extraction protocol has no other effect on the structure or 
function of skeletal muscle fibres (Ferguson et al. 2003; Sun et al. 2006). Trabeculae were 
then incubated in relaxing solution containing 1.8 mg/ml TnC-BR55-62 or TnC-BR95-102 for 30 
min at 20 °C, and the extent of TnC reconstitution was estimated from force at maximal Ca2+ 
activation. No further increase in force was produced by longer incubation in TnC.  
 
Measurement of TnC helix orientation by polarised fluorescence 
Polarised fluorescence intensities were measured as described previously for skeletal muscle 
fibres (Sun et al. 2006).  A central 0.7-mm segment of a trabecula was briefly illuminated 
from below with 532 nm light polarised either parallel or perpendicular to the trabecular axis. 
BR fluorescence at 610 nm was collected both in line with the illuminating beam and at 90° 
to both the illuminating beam and the trabecular axis. Each emitted beam was separated into 
parallel and perpendicular components, and three independent orientation order parameters 
were calculated from the measured intensities: <P2d>, describing the amplitude of rapid (sub-
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nanosecond) probe motion and <P2> and <P4>, describing the distribution of angles θ 
between BR fluorescence dipole and thin filament axis averaged over slower timescales (Dale 
et al. 1999). A mean θ was estimated for a Gaussian orientation distribution (standard 
deviation σg) and reported as θf, the mean axial angle of the distribution in the trabecular co-
ordinate frame formed by folding the tail of the molecular Gaussian distribution into the 
region of positive θ (Julien et al. 2007). 
Each trabecular activation was preceded by a 1-min incubation in pre-activating 
solution. Isometric force and fluorescence intensities were measured after steady-state force 
had been established in each activation. Maximum force was recorded before and after each 
series of activations at sub-maximal [Ca2+], and was 37.9 ± 1.6 mN mm-2 (cross sectional 
area 18724 ± 2242 μm2, n=14) before TnC extraction. If the maximum force decreased by 
>15%, the trabecula was discarded. The dependence of force and θf on [Ca2+] was fitted to 
data from individual trabeculae using nonlinear least-squares regression to the Hill equation: 
)][Ca/(EC][CaY HHH 2502 nnn ++ +=  
where EC50 is the [Ca2+] corresponding to half-maximal change in Y, and nH is the Hill 
coefficient. All values are given as mean ± standard error except where noted, with n 
representing the number of trabeculae. 
 
 
Results 
Incorporation of labelled TnC into cardiac muscle cells 
The in situ orientation of the C helix of TnC in the N-terminal regulatory lobe (Fig. 1A) was 
determined by replacing about two-thirds of the native TnC of demembranated ventricular 
trabeculae by TnC-BR55-62, in which residues 55 and 62 were cross-linked with bifunctional 
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rhodamine (BR). Maximum Ca2+-activated isometric force after TnC exchange was 82 ± 3% 
(n=5) of that before exchange (Table 1). Incorporation of unlabelled wild-type TnC by the 
same protocol produced the same small reduction of maximum force, consistent with a non-
specific effect of the TnC exchange protocol. The dependence of force after TnC exchange 
on free [Ca2+] was fitted by the Hill equation (Fig. 1B, triangles). The [Ca2+] giving half-
maximum force (EC50) was 5.40 ± 0.57 µM (n=5) and the Hill coefficient (nH), describing the 
steepness of the Ca2+-dependence, was 3.10 ± 0.24 (Table 1). EC50 clearly increased 
following TnC exchange, but nH did not change significantly (P > 0.05, paired comparison).  
The orientation of the E helix in the C-terminal lobe of TnC, part of the IT arm in the 
troponin ternary complex (Fig. 1A), was determined using a TnC mutant with bifunctional 
rhodamine cross-linking residues 95 and 102 (TnC-BR95-102). Active isometric force after 
replacement of native TnC by TnC-BR95-102 was 84 ± 2 % (n=5) of that before TnC exchange 
(Table 1). EC50 for force increased after the introduction of TnC-BR95-102, but there was no 
significant change in nH. Thus, as in case of the C helix probe, introduction of the BR probe 
on the E helix of TnC reduced the Ca2+ affinity of the regulatory site of TnC with no 
significant effect on the steepness of the force-Ca2+ relationship. The reduced Ca2+ affinity 
appears to be related to the presence of the BR probe on either the C or E helix, since there 
was no significant change in EC50 following exchange of wild-type TnC (Table 1).  
 
In situ orientation of the C and E helices of troponin C 
The orientation of the BR fluorescence dipole, and thus of the C or E helix of TnC to which it 
was attached, was determined from the polarization of fluorescence from trabeculae 
containing BR-TnC (Corrie et al. 1999; Ferguson et al. 2003; Sun et al. 2006). For a 
cylindrically symmetrical muscle cell, the results can be expressed in terms of a set of order 
parameters that describe the orientation distribution of the BR dipoles with respect to the 
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trabecular axis (Dale et al. 1999), and these order parameters are reported in Supplementary 
Table 1. We used a Gaussian model of these dipole orientation distributions with peak angle 
θf and standard deviation σg (Julien et al. 2007), to describe the main features of the 
orientation changes. θf increased by about 5° on Ca2+-activation of the trabeculae, for both 
the C helix (Fig. 1B, circles) and the E helix (Fig. 1C, circles; Table 2). Although these 
orientation changes are small, they were highly reproducible. There was no significant 
change in probe dispersion σg on Ca2+-activation. 
The Ca2+-dependence of the θf changes was described using the Hill equation, which 
gave a good fit to the data for the C helix probe (Fig. 1B, dashed line), with EC50 6.01 ± 0.54 
µM and nH 3.0 ± 0.1 (n=5). These values were not significantly different from those for force 
in the same trabeculae (Fig. 1B, triangles, continuous line). θf for the E helix probe (Fig. 1C, 
circles) showed a small additional component in the sub-threshold range for activation, as 
observed previously for monofunctional probes on Cys84 of TnC (Bell et al. 2006). This 
component, which may be associated with Ca2+ binding to the  Ca2+/Mg2+ sites near the E 
helix (Fig. 1A), could be partly responsible for the offset between the Ca2+-dependence of θf 
for this probe and force (Fig. 1C). The major component of the E helix orientation change for 
[Ca2+] > 1 µM was fitted to the Hill equation (dashed line), with EC50 = 4.60 ± 0.50 µM. nH 
was close to 3, similar to that for force in these trabeculae, and to the values reported above 
for the C helix (Table 2). 
The EC50 values for the major component of the changes in orientation of the C and E 
helices are consistent with the Ca2+-affinity of the regulatory site of troponin (Holroyde et al. 
1980; Pan & Solaro, 1987). The structural changes in both regions of troponin have a Ca2+-
dependence similar to that of force. Thus, as [Ca2+] is varied, force is linearly related to the 
structural change in troponin, as expected for a simple two-state model in which troponin 
molecules are in either a Ca2+-free OFF or a Ca2+-bound ON state, with force proportional to 
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the fraction ON. Ca2+-control of both the structural change and force are highly co-operative, 
however, as indicated by nH values close to 3.  
 
Effect of Force-Generating Myosin Heads on Troponin Orientation 
To determine the effect of force-generating myosin heads on these changes in troponin 
structure, we reduced active force to 1.6 ± 0.6% (n=8) of the control value using 25 μM 
blebbistatin. This is a small molecule which binds specifically with high affinity to the actin-
binding cleft of cardiac myosin, preventing strong binding to actin (Straight et al. 2003; 
Allingham et al. 2005), and inhibiting actomyosin ATPase activity (Kovacs et al. 2004; 
Farman et al. 2008) and active force generation by cardiac muscle (Dou et al. 2007; Farman 
et al. 2008). The Ca2+-dependence of the orientation of the C helix of TnC after inhibition of 
active force by blebbistatin (Fig. 2A, circles) was almost identical to that in control conditions 
(dashed line). EC50 increased slightly (P < 0.05, paired comparison), but there was no 
significant change in nH, which remained close to 3 (Table 2). These results provide strong 
evidence that the co-operativity of the Ca2+-dependent change in troponin structure is not due 
to force-generating myosin heads. Similar results were obtained for the E helix probe (Fig. 
2B), although here the quantitative interpretation is complicated by the biphasic orientation 
change noted above. Unexpectedly, blebbistatin reduced θf for the E helix by about 1° over 
the whole range of [Ca2+]. The Hill equation fit to θf for [Ca2+] > 1 µM (continuous line) 
again had nH close to 3 (Table 2), as in control conditions (dashed line), and EC50 was larger 
than in control conditions (P < 0.05), as observed for the C helix probe. 
 
Effect of Myosin Head Binding in Rigor on Troponin Orientation 
The results described in the previous section show that the steep Ca2+-dependence of active 
force generation is not due to binding of force-generating myosin heads to the thin filaments. 
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However it is well established that myosin head binding can activate the thin filaments at 
very low [MgATP], when myosin makes a rigor bond with actin (Bremel & Weber, 1972). 
Myosin binding in rigor conditions also increases the Ca2+ affinity of TnC (Rosenfeld & 
Taylor, 1985; Robinson et al. 2004). To clarify the mechanisms operating in the two sets of 
conditions, we measured the structural changes in TnC using the C- and E-helix TnC probes 
in ventricular trabeculae in rigor conditions.  
Binding of myosin heads to actin in rigor conditions produced changes in the 
orientation of both helices even at 1 nM [Ca2+] (Table 2). θf for the C helix increased by 2.5° 
and θf for the E helix by ca 8°. The change in the orientation of the E helix was larger than 
that produced by Ca2+ binding during physiological activation at 5 mM MgATP. Binding of 
rigor heads also increased the dispersion of the probe orientations (σg); for example, σg for 
the E-helix probe increased from 22.9 ± 0.4° at 5mM MgATP to 30.2 ± 2.2° in rigor at 1 nM 
[Ca2+]. This broadening of the orientation distributions in rigor contrasts with the absence of 
any significant change in σg when trabeculae were activated at 5mM MgATP (Table 2).   
Addition of Ca2+ in rigor produced further increases in θf (Fig. 3A,B, circles; Table 2), 
but these were spread over a much wider range of [Ca2+] than during physiological activation 
at 5 mM MgATP (dashed lines). For quantitative analysis of the Ca2+ dependence in rigor, we 
took into account that only about two-thirds of the troponin molecules in trabeculae at 
sarcomere length 2.15 μm are located in the overlap region of the thin filament where 
myosins are available for binding (Fig 3, inset). The θf data (Fig. 3, circles) were therefore 
fitted by the sum of two Hill equations (continuous lines), with the relative amplitude of the 
two components as a free parameter. The best fit was obtained when two-thirds of the total 
angle change was accounted for by a component with EC50 0.25–0.28 µM and nH 0.7–1.1 for 
both the C and E helix probes (Table 2) that we associate with the overlap region (black 
arrow). These values of EC50 and nH are similar to those measured for conformational 
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changes of troponin in the rigor complex in solution (Robinson et al. 2004). The remaining 
one-third was accounted for by a component with EC50 4.4–4.8 µM for both the C and E 
helices, close to that for physiological activation at 5 mM MgATP, associated with the non-
overlap region (grey arrow). nH for this component could not be determined precisely, but 
was 2.2 ± 0.3 and 2.2 ± 0.6 for the C and E helices respectively, consistent with a degree of 
co-operativity that is similar to or somewhat lower than that measured during physiological 
activation. These results suggest that, even in rigor conditions, the non-overlap region of the 
thin filament exhibits a co-operative structural change on binding Ca2+ that is independent of 
local myosin binding.  
 
 
Discussion   
Co-operative Ca2+ regulation of cardiac contractility is intrinsic to the thin 
Filament 
The results presented above can be explained by a simple two-state model for Ca2+ regulation 
of contraction in heart muscle. The Ca2+-driven transition between the two states is co-
operative, in the sense that the Ca2+-dependence of changes in troponin structure and force 
both have a Hill coefficient (nH) close to 3. However this co-operativity is not due to force-
generating myosin heads, because it is not affected by specific inhibition of active force by 
blebbistatin. We conclude that the mechanism of co-operativity must be intrinsic to the thin 
filaments. Such a mechanism has been inferred previously from solution studies, and is likely 
to involve tropomyosin-mediated coupling between troponin monomers along the thin 
filament and/or between its two strands (Tobacman, 1996; Tobacman & Sawyer, 1990; 
Galinska-Rakoczy et al. 2008). The present conclusion is at variance with the alternative 
hypothesis that myosin binding plays a dominant role in switching on the thin filaments 
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during activation of heart muscle, and three-state model of regulation associated with this 
concept (McKillop & Geeves, 1993; Gordon et al. 2000; Kobayashi & Solaro, 2005). The 
next three sections reconsider the evidence for the myosin activation hypothesis in the light of 
the present results. 
 
Rigor and active force-generating myosin heads have distinct effects on 
troponin structure 
Activation of thin filaments by rigor binding of myosin heads, accompanied by an order of 
magnitude increase in the affinity of troponin for Ca2+, is a well-established phenomenon 
(Bremel & Weber, 1972; Rosenfeld & Taylor, 1985; Robinson et al. 2004), and the rigor 
state has been widely used as a convenient model for the force-generating myosin heads 
during active contraction at physiological [MgATP] in both molecular- and cell-level studies. 
The present results, however, show that rigor and force-generating myosin heads have 
distinct effects on Ca2+-dependent changes in troponin structure. In rigor, the change in 
troponin structure is characterized by a Ca2+ affinity an order of magnitude greater than in 
physiological conditions, but there is no co-operativity (nH close to 1), in contrast with 
physiological conditions (nH close to 3). Ca2+ titrations in rigor indicated the presence of two 
populations of troponin molecules, corresponding to those in the overlap region of the 
sarcomere where rigor heads have an effect, and the non-overlap region where they do not. 
The larger Gaussian width (σg) of the orientation distributions in rigor also suggests the 
presence of two populations of troponin molecules. At physiological [MgATP], in contrast, 
only one population of troponin molecules is present, implying that troponins in the overlap 
and non-overlap regions of the sarcomere have the same Ca2+-dependence and providing 
further evidence for the absence of an effect of active force-generating myosin heads on 
troponin structure. In summary, the present results show that the effect of myosin binding to 
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actin in rigor conditions is not a reliable model for its effect on troponin structure and thin 
filament activation under physiological conditions.  
 
Previous studies of troponin structure and Ca2+-binding in muscle cells 
The present work differs from previous studies that used extrinsic probes to investigate 
changes in troponin structure in heart muscle at physiological [MgATP] in two key respects. 
First, we used bifunctional probes to measure the orientation of specific troponin helices; 
previous studies used monofunctional probes in which the orientation and motion of the 
probe with respect to the protein was unknown, and different results were obtained with 
different probe sites (e.g. Putkey et al. 1997; Martyn et al. 2001). Second, none of the 
previous studies used blebbistatin to inhibit active force generation and thereby determine the 
role of force-generating myosin heads on thin filament activation. Blebbistatin is a more 
potent and specific inhibitor than the millimolar vanadate used in previous studies of 
structural changes in TnC reported by fluorescent probes (Martyn et al. 2001; Bell et al. 2006) 
and of direct Ca2+ binding (Hofmann & Fuchs, 1987; Wang & Fuchs, 1994). TnC can be 
extracted from skeletal muscle fibers in solutions containing millimolar vanadate (Allhouse et 
al. 1999; Agianian et al. 2004), and both TnC and TnI are extracted from cardiac muscle in 
these conditions (Strauss et al. 1992). Thus the effects of vanadate reported in previous 
studies of troponin structure and Ca2+ binding may not have been solely due to its inhibition 
of myosin.  
 
Shortening -dependence of Ca2+ activation 
Shortening of heart muscle cells during activation produces a transient increase in 
intracellular free [Ca2+] (Allen & Kurihara, 1982; Gordon & Ridgway; 1987; Allen & 
Kentish, 1988), indicating a decrease in the Ca2+ affinity of troponin.  Since fewer myosin 
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heads are bound to thin filaments during shortening, these transient [Ca2+] increases suggest 
that myosin head binding can affect the Ca2+ affinity of troponin under physiological 
conditions, in apparent contradiction with the present results. However the affinity change 
implied by these [Ca2+] transients is small. For example, with nH = 3 and free [Ca2+] = 6 μM 
an increase in EC50 from 6 to 7 μM, similar to that observed for the C helix probe when force 
was inhibited by blebbistatin (Table 1), would release about 8 μM total Ca2+ from the ca 
70μM troponin in a heart muscle cell. This could account for the observed changes in free 
[Ca2+] given reasonable estimates of intracellular Ca2+ buffering (Berlin et al. 1994). The 
small increase in EC50 associated with force inhibition suggests that the troponin ON state is 
slightly favoured by binding of force-generating myosin heads, as expected from a regulatory 
mechanism in which both processes are coupled to tropomyosin movement. This small effect 
of force-generating myosin heads on Ca2+ affinity (an order of magnitude smaller than that of 
rigor myosin heads) might be accompanied by a similarly small effect of force inhibition by 
blebbistatin on the Hill coefficient nH (Table 1), although no such change was detectable at 
the 5% significance level in the present experiments. The finding that almost normal co-
operativity of Ca2+-regulation was maintained in the presence of blebbistatin argues strongly 
against a dominant role for myosin-dependent affinity changes in the co-operative response to 
Ca2+ binding.   
 
Changes in troponin structure during Ca2+ activation 
The change in troponin structure during activation of ventricular trabeculae reported by 
probes on the C and E helices of TnC corresponds to a change in the angle between each 
helix and the actin filament axis of only about 5°.  In isolated TnC in solution, the angle 
between the C and D helices of TnC  changes by 12° on binding Ca2+, and by 34° on binding 
both Ca2+ and the switch peptide (residues 147-163) of TnI (Sia et al. 1997; Li et al. 1999). 
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These C/D angle changes are associated with opening of the N-lobe of TnC, exposing a 
hydrophobic binding site for the TnI switch peptide, and are thought to represent an essential 
step in the signalling pathway that leads to muscle activation. The present results do not 
exclude the possibility that the N-lobe opens in this way during physiological activation of 
heart muscle, but if so the motion of the C helix must be predominantly azimuthal, i.e. around 
the filament axis. Further experiments with probes at other sites on TnC will be required to 
characterise this motion and measure the extent of N-lobe opening in situ. However the 
comparison of the ca 5° C-helix tilt observed here with the ca 27° tilt of the same helix in 
skeletal muscle (Sun et al. 2006) already shows that the underlying conformational changes 
in the N-lobe of TnC on activation are different in skeletal and cardiac muscle. In skeletal 
muscle, the whole N-lobe seems to tilt substantially with respect to the C-lobe, IT arm, and 
thin filament during activation (Sun et al. 2006). The present results suggest that this motion 
does not occur in cardiac muscle, but the structural basis and physiological significance of 
this difference remain to be elucidated. 
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Figure legends  
Fig. 1. Orientation changes of the C and E helices of troponin C on binding Ca2+. (A) 
Structure of core complex of cardiac troponin in the Ca2+-saturated form (ref 4; PDB 1J1D); 
containing troponin C (TnC; red, green) and parts of troponin I (TnI; blue, cyan) and troponin 
T (TnT; gold). Bifunctional rhodamine probes cross-linked either cysteines 55 and 62 (yellow 
spheres) along the C helix or 95 and 102 along the E helix of TnC. (B) and (C) Orientation (θf, 
circles) of the C and E helices of TnC respectively and isometric force (triangles) in the same 
sets of trabeculae in the presence of 5 mM MgATP. The dashed and continuous lines are fits 
of the Hill equation to θf and force respectively. Error bars denote SEM for n=5 trabeculae. 
 
Fig. 2. Effect of force inhibition by 25μM blebbistatin on the orientation of (A) the C and (B) 
the E helix of TnC in the presence of 5 mM MgATP. Circles denote θf in the presence of 
blebbistatin, continous lines denote Hill fits to these data, and dashed lines are from the Hill 
fits in Fig. 1, in the absence of blebbistatin. 
 
Fig. 3. The orientation of (A) the C and (B) the E helix of TnC in the absence of MgATP. 
Circles denote θf, continous lines denote double Hill equation fits described in the text, and 
dashed lines are from the Hill fits in Fig. 1 for 5mM MgATP. The inset shows the degree of 
overlap between the myosin and thin filaments at the sarcomere length used in these 
experiments. 
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Table 1. Ca2+-dependence of isometric force (mean ± SEM). 
 C helix; TnC-BR55-62 
(n=5) 
E helix; TnC-BR95-102 
(n=5) 
Wild-type 
TnC 
(n=4) 
Before TnC reconstitution   
EC50 (µM) 2.53 ± 0.21 1.82 ± 0.33 1.29 ± 0.25 
nH 3.51 ± 0.48 3.59 ± 0.15 3.57 ± 0.45 
After TnC reconstitution   
Maximum force 0.82 ± 0.03 0.84 ± 0.02 0.82 ± 0.01 
EC50 (µM) 5.40 ± 0.57 3.17 ± 0.49 1.54 ± 0.3 
nH 3.10 ± 0.24 2.92 ± 0.25 3.13 ± 0.43 
 
EC50 and nH are fitted parameters of the Hill equation (see Materials and Methods). 
Maximum Ca2+-saturated force was measured after TnC exchange as a fraction of that in the 
same trabeculae before exchange. 
24 
 
Table 2. Ca2+- dependence of troponin C orientation parameters  
 
 
 
 
 
 
 
 
 
Mean ± SEM. Comparison: paired t-test, two-tailed; ns, P>0.05; *, P<0.05. 
 
 C helix; TnC-BR55-62  E helix; TnC-BR95-102 
5 mM MgATP 
 
(n=5) 
5 mM MgATP + 
25 µM Blebbistatin 
(n=4) 
0 mM MgATP, 
Rigor 
(n=5) 
5 mM MgATP 
 
(n=5) 
5 mM MgATP + 
25 µM Blebbistatin 
(n=4) 
0 mM MgATP, 
Rigor 
(n=4) 
θf (°)        
1 nM [Ca2+]  52.3 ± 0.2 52.2 ± 0.2 ns 54.8 ± 0.1 *  46.3 ± 0.2 45.5 ± 0.1 54.4 ± 0.4 
Maximal [Ca2+]  57.4 ± 0.2 57.0 ± 0.2 * 57.9 ± 0.1 * 
 
50.0 ± 0.3 48.4 ± 0.2 56.9 ± 0.4 
First Hill fit        
Amplitude (°)  5.04 ± 0.12 4.81 ± 0.05 1.12 ± 0.27  4.29 ± 0.34 3.70 ± 0.26 0.95 ± 0.20 
EC50 (µM) 6.01 ± 0.54 7.29 ± 0.71 * 4.83 ± 0.44  4.60 ± 0.50 7.39 ± 1.00 4.37 ± 0.45 
nH 3.01 ± 0.13 2.86 ± 0.27 ns 2.24 ± 0.33  3.06 ± 0.32 2.85 ± 0.13 2.21 ± 0.64 
Second Hill fit        
Amplitude (°)   1.97 ± 0.20    1.59 ± 0.18 
EC50 (µM)   0.28 ± 0.08    0.25 ± 0.05 
nH   1.05 ± 0.12    0.73 ± 0.04 
σg (°)        
1 nM [Ca2+]  24.3 ± 0.4 24.9 ± 0.2 27.4 ± 1.3 
 
22.9 ± 0.4 23.4 ± 0.5 30.2 ± 2.2 
Maximal [Ca2+]  24.8 ± 0.6 25.1 ± 0.3 26.0 ± 1.1  22.6 ± 0.6 22.5 ± 0.5 30.8 ± 2.8 
 B 
1001010.10.001
52
54
56
58
0.0
0.2
0.4
0.6
0.8
1.0
[Ca] (μM)
θ f
(°)
R
elative force
1001010.10.001
45
47
49
51
0.0
0.2
0.4
0.6
0.8
1.0
[Ca] (μM)
θ f(
°)
R
elative force
A 
Regulatory 
lobe 
IT arm
C 
 A 
56
54
52
1001010.10.001
44
46
48
50
[Ca] (μM)
θ f(
°)
B 
1000.001 0.1 1
58
[Ca] (μM)
θ f(
°)
10
 Myosin
Actin
1001010.10.001
45
47
49
51
53
55
57
[Ca] (μM)
θ f(
°)
A 
B 
1001010.10.001
52
54
56
58
[Ca] (μM)
θ f(
°)
